Coleen T. Murphy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Coleen T. Murphy has a total of 218 co-authors. Here are the top co-authors by number of shared publications:
- Rachel Kaletsky
Princeton University
49 shared publications - Rebecca Sydney Moore
Department of Neuroscience, Chronobiology and Sleep Institute University of Pennsylvania, Philadelphia, PA, USA
16 shared publications - Cheng Shi
Princeton University
12 shared publications - Salman Sohrabi
Department of Bioengineering, The University of Texas at Arlington, Arlington, TX 76019, USA
9 shared publications - Lance Parsons
LSI Genomics, Princeton University, Princeton, NJ 08544, USA
8 shared publications - Rachel N. Arey
Center for Precision Environmental Health, Baylor College of Medicine
8 shared publications
Latest Publications
- Open Access
Glial cells gate small RNA transport from germline to brain during transgenerational epigenetic inheritance of behavior
SUMMARY: How circulating RNAs reach their target tissue is not well understood. In C. elegans , small RNA signals that convey exposure to pathogenic Pseudomonas travel from the intestine to germline to neurons, allowing both learned pathogen avoidance and the transgenerational inheritance of this information for four generations – but how this Cer1 retrotransposon-bound RNA signal reaches the nervous system was previously unknown. We found that the RNA transporter SID-1, long thought to act in the intestine or germline, instead functions in a single cell type, the amphid sheath glia, where it is necessary and sufficient for learned avoidance. SID-1 mediates uptake of germline-derived RNA, followed by transcytosis to a neighboring sensory neuron, where the P11 target gene maco-1 is silenced. This glial “filter”, which uses highly conserved molecular components to transcytose RNAs to neurons, reveals a general mechanism for gating small RNA access to the nervous system, paralleling the mammalian blood-brain barrier.
Open AccessGlial cells gate small RNA transport from germline to brain during transgenerational epigenetic inheritance of behavior
SUMMARY: How circulating RNAs reach their target tissue is not well understood. In C. elegans , small RNA signals that convey exposure to pathogenic Pseudomonas travel from the intestine to germline to neurons, allowing both learned pathogen avoidance and the transgenerational inheritance of this information for four generations – but how this Cer1 retrotransposon-bound RNA signal reaches the nervous system was previously unknown. We found that the RNA transporter SID-1, long thought to act in the intestine or germline, instead functions in a single cell type, the amphid sheath glia, where it is necessary and sufficient for learned avoidance. SID-1 mediates uptake of germline-derived RNA, followed by transcytosis to a neighboring sensory neuron, where the P11 target gene maco-1 is silenced. This glial “filter”, which uses highly conserved molecular components to transcytose RNAs to neurons, reveals a general mechanism for gating small RNA access to the nervous system, paralleling the mammalian blood-brain barrier.
- Open Access
- 27 April 2026
- Published by Springer Nature in Research Square
COMPASS-mediated epigenetic regulation of transcription accelerates forgetting with age
The molecular regulation of forgetting and its acceleration with age are not understood. Here we discovered that active gene transcription, rather than solely mRNA translation, is required for forgetting. We found that the subunits of SET1/COMPASS, a conserved histone methyltransferase complex associated with active transcription, are upregulated in aged C. elegans neurons, mirroring their age-related increase in mammalian brain regions governing memory. Reduction of SET1/COMPASS components blocks forgetting in both young and old animals. Optogenetic manipulation, degron-mediated conditional knockdown, pharmacological and genetic inhibition, neuronal RNA-Seq, and neuronal chromatin profiling reveal that SET1/COMPASS promotes activity-dependent de novo transcription in an olfactory sensory neuron that erases the associative memory trace in downstream neurons via neuropeptide signaling, resulting in forgetting. Increased SET1/COMPASS-dependent chromatin accessibility at these loci primes transcription, accelerating forgetting with age. Rescue with human SET1A and an inhibitor of human COMPASS underscore the conservation of this pathway from worms to humans. Our results identify SET1/COMPASS-mediated de novo gene transcription as a mechanism of forgetting, implicating increased expression of COMPASS components as a conserved driver of cognitive decline with age.
- 27 April 2026
- Published by Springer Nature in Research Square
Open AccessCOMPASS-mediated epigenetic regulation of transcription accelerates forgetting with age
The molecular regulation of forgetting and its acceleration with age are not understood. Here we discovered that active gene transcription, rather than solely mRNA translation, is required for forgetting. We found that the subunits of SET1/COMPASS, a conserved histone methyltransferase complex associated with active transcription, are upregulated in aged C. elegans neurons, mirroring their age-related increase in mammalian brain regions governing memory. Reduction of SET1/COMPASS components blocks forgetting in both young and old animals. Optogenetic manipulation, degron-mediated conditional knockdown, pharmacological and genetic inhibition, neuronal RNA-Seq, and neuronal chromatin profiling reveal that SET1/COMPASS promotes activity-dependent de novo transcription in an olfactory sensory neuron that erases the associative memory trace in downstream neurons via neuropeptide signaling, resulting in forgetting. Increased SET1/COMPASS-dependent chromatin accessibility at these loci primes transcription, accelerating forgetting with age. Rescue with human SET1A and an inhibitor of human COMPASS underscore the conservation of this pathway from worms to humans. Our results identify SET1/COMPASS-mediated de novo gene transcription as a mechanism of forgetting, implicating increased expression of COMPASS components as a conserved driver of cognitive decline with age.
- Open Access
Pharmacologic AMPK Activation Extends Lifespan in C. elegans and Improves Aspects of Healthspan in Mice
Dysregulated energy metabolism is a hallmark of aging. Many interventions that extend lifespan converge on the conserved master regulator of energy metabolism, AMP-activated kinase (AMPK), and direct genetic activation of AMPK extends lifespan in multiple species. Here, we test the ability of a specific and potent pharmacologic AMPK activator, MK-8722, to extend lifespan in C. elegans and improve healthspan in aged mice. Treatment with MK-8722 from adulthood significantly extended lifespan in an AMPK-dependent manner in both wildtype and Cockayne syndrome model csb-1 mutant C. elegans, without impairing motility or reproductive capacity. Mice treated with MK-8722 from 18 until 24 months of age had significantly reduced body fat accumulation, blocked age-associated declines in fasting blood glucose and enhanced circadian rhythmicity in respiratory quotient, suggesting an improved overall metabolic state. Hepatic RNA sequencing revealed a decrease in inflammation-related pathways and an increase in sterol metabolic pathways, which was consistent with significantly increased levels of multiple sterol-derived metabolites, including lithocholic acid, a proposed mediator of the benefits of caloric restriction. Our results support pharmacologic AMPK activation as a promising gerotherapeutic strategy.
Open AccessPharmacologic AMPK Activation Extends Lifespan in C. elegans and Improves Aspects of Healthspan in Mice
Dysregulated energy metabolism is a hallmark of aging. Many interventions that extend lifespan converge on the conserved master regulator of energy metabolism, AMP-activated kinase (AMPK), and direct genetic activation of AMPK extends lifespan in multiple species. Here, we test the ability of a specific and potent pharmacologic AMPK activator, MK-8722, to extend lifespan in C. elegans and improve healthspan in aged mice. Treatment with MK-8722 from adulthood significantly extended lifespan in an AMPK-dependent manner in both wildtype and Cockayne syndrome model csb-1 mutant C. elegans, without impairing motility or reproductive capacity. Mice treated with MK-8722 from 18 until 24 months of age had significantly reduced body fat accumulation, blocked age-associated declines in fasting blood glucose and enhanced circadian rhythmicity in respiratory quotient, suggesting an improved overall metabolic state. Hepatic RNA sequencing revealed a decrease in inflammation-related pathways and an increase in sterol metabolic pathways, which was consistent with significantly increased levels of multiple sterol-derived metabolites, including lithocholic acid, a proposed mediator of the benefits of caloric restriction. Our results support pharmacologic AMPK activation as a promising gerotherapeutic strategy.
- Open Access
Exposure to deceased remains of conspecifics extends the lifespan of young and aged C. elegans via distinct pathways
Signaling factors, both external from an organism′s environment and produced internally by its tissues, regulate the rate of aging. Loss of beneficial signals drives systemic aging, and conversely, restoring these youth-associated signals can rejuvenate an aging individual, as demonstrated by heterochronic parabiosis. Finding factors that promote organismal health and longevity therefore holds great therapeutic promise to slow aging and age-associated disease. Here, we report that exposure to the lysed remains of other worms extends C. elegans lifespan. This lifespan extension is not mediated by ascaroside pheromones and is not induced by bacterial cell lysate, suggesting that this effect is not merely produced by nutritional supplementation of cellular contents. We find that a period of discrete exposure at any point across the lifespan is sufficient to induce longevity. However, distinct pathways were activated in young and aged recipients; we found that lysate factors act through insulin/insulin-like growth factor/FOXO signaling (IIS) in young worms, while IIS-independent pathways extend lifespan in older worms. Using fluorescent gene reporter lines, we provide evidence that intestinal IIS is not activated in young worms, suggesting that lysate signals promote longevity via non-intestinal tissues. Our work identifies a novel longevity paradigm in which the remains of deceased C. elegans extend the lifespans of living conspecifics through multiple parallel pathways.
Open AccessExposure to deceased remains of conspecifics extends the lifespan of young and aged C. elegans via distinct pathways
Signaling factors, both external from an organism′s environment and produced internally by its tissues, regulate the rate of aging. Loss of beneficial signals drives systemic aging, and conversely, restoring these youth-associated signals can rejuvenate an aging individual, as demonstrated by heterochronic parabiosis. Finding factors that promote organismal health and longevity therefore holds great therapeutic promise to slow aging and age-associated disease. Here, we report that exposure to the lysed remains of other worms extends C. elegans lifespan. This lifespan extension is not mediated by ascaroside pheromones and is not induced by bacterial cell lysate, suggesting that this effect is not merely produced by nutritional supplementation of cellular contents. We find that a period of discrete exposure at any point across the lifespan is sufficient to induce longevity. However, distinct pathways were activated in young and aged recipients; we found that lysate factors act through insulin/insulin-like growth factor/FOXO signaling (IIS) in young worms, while IIS-independent pathways extend lifespan in older worms. Using fluorescent gene reporter lines, we provide evidence that intestinal IIS is not activated in young worms, suggesting that lysate signals promote longevity via non-intestinal tissues. Our work identifies a novel longevity paradigm in which the remains of deceased C. elegans extend the lifespans of living conspecifics through multiple parallel pathways.
- Open Access
Caenorhabditis elegans avoids Todstoff, a novel nociceptive necrotaxis cue
To survive in hazardous environments, organisms must navigate and avoid myriad threats. Many species across phyla detect warning cues in the remains of dead or injured conspecifics, allowing them to enact defensive strategies and avoid a similar fate. Here, we demonstrate that Caenorhabditis elegans senses a novel aversive cue (which we term ′Todstoff′, or ′death substance′) present in the remains of dead worms that induces living conspecifics to perform negative necrotaxis behaviors. Todstoff is distinct from previously-identified social signals in C. elegans, including ascaroside and alarm pheromones, and biochemical analysis suggests that Todstoff is a protein-associated small molecule of less than 2 kDa. We determined that Todstoff is sensed by the ASH polymodal nociceptive neurons, and further, that the necrotaxis signal is transduced via the activity of G-protein coupled receptor (GPCR) signaling, the Gi/o-like protein ODR-3, TRPV channels OSM-9 and OCR-2, and glutamatergic synaptic transmission to downstream AIB interneurons. Taken together, our work illuminates a post-mortem inter-animal chemical signaling pathway that promotes death avoidance, and thus, survival.
Open AccessCaenorhabditis elegans avoids Todstoff, a novel nociceptive necrotaxis cue
To survive in hazardous environments, organisms must navigate and avoid myriad threats. Many species across phyla detect warning cues in the remains of dead or injured conspecifics, allowing them to enact defensive strategies and avoid a similar fate. Here, we demonstrate that Caenorhabditis elegans senses a novel aversive cue (which we term ′Todstoff′, or ′death substance′) present in the remains of dead worms that induces living conspecifics to perform negative necrotaxis behaviors. Todstoff is distinct from previously-identified social signals in C. elegans, including ascaroside and alarm pheromones, and biochemical analysis suggests that Todstoff is a protein-associated small molecule of less than 2 kDa. We determined that Todstoff is sensed by the ASH polymodal nociceptive neurons, and further, that the necrotaxis signal is transduced via the activity of G-protein coupled receptor (GPCR) signaling, the Gi/o-like protein ODR-3, TRPV channels OSM-9 and OCR-2, and glutamatergic synaptic transmission to downstream AIB interneurons. Taken together, our work illuminates a post-mortem inter-animal chemical signaling pathway that promotes death avoidance, and thus, survival.
- Open Access
- 18 December 2025
- Published by Elsevier in STAR Protocols
- Vol. 7 (1) , 104278
Protocol for single-nucleus RNA sequencing of adult C. elegans neurons
- 18 December 2025
- Published by Elsevier in STAR Protocols
- Vol. 7 (1) , 104278
Open AccessProtocol for single-nucleus RNA sequencing of adult C. elegans neurons
- Open Access
COMPASS-mediated epigenetic regulation of transcription accelerates forgetting with age
The molecular regulation of forgetting and its acceleration with age are not understood. Here we discovered that active gene transcription, rather than solely mRNA translation, is required for forgetting. We found that the subunits of SET1/COMPASS, a conserved histone methyltransferase complex associated with active transcription, are upregulated in aged C. elegans neurons, mirroring their age-related increase in mammalian brain regions governing memory. Reduction of SET1/COMPASS components blocks forgetting in both young and old animals. Optogenetic manipulation, degron-mediated conditional knockdown, pharmacological and genetic inhibition, neuronal RNA-Seq, and neuronal chromatin profiling reveal that SET1/COMPASS promotes activity-dependent de novo transcription in an olfactory sensory neuron that erases the associative memory trace in downstream neurons via neuropeptide signaling, resulting in forgetting. Increased SET1/COMPASS-dependent chromatin accessibility at these loci primes transcription, accelerating forgetting with age. Rescue with human SET1A and an inhibitor of human COMPASS underscore the conservation of this pathway from worms to humans. Our results identify SET1/COMPASS-mediated de novo gene transcription as a mechanism of forgetting, implicating increased expression of COMPASS components as a conserved driver of cognitive decline with age.
Open AccessCOMPASS-mediated epigenetic regulation of transcription accelerates forgetting with age
The molecular regulation of forgetting and its acceleration with age are not understood. Here we discovered that active gene transcription, rather than solely mRNA translation, is required for forgetting. We found that the subunits of SET1/COMPASS, a conserved histone methyltransferase complex associated with active transcription, are upregulated in aged C. elegans neurons, mirroring their age-related increase in mammalian brain regions governing memory. Reduction of SET1/COMPASS components blocks forgetting in both young and old animals. Optogenetic manipulation, degron-mediated conditional knockdown, pharmacological and genetic inhibition, neuronal RNA-Seq, and neuronal chromatin profiling reveal that SET1/COMPASS promotes activity-dependent de novo transcription in an olfactory sensory neuron that erases the associative memory trace in downstream neurons via neuropeptide signaling, resulting in forgetting. Increased SET1/COMPASS-dependent chromatin accessibility at these loci primes transcription, accelerating forgetting with age. Rescue with human SET1A and an inhibitor of human COMPASS underscore the conservation of this pathway from worms to humans. Our results identify SET1/COMPASS-mediated de novo gene transcription as a mechanism of forgetting, implicating increased expression of COMPASS components as a conserved driver of cognitive decline with age.
- 6 October 2025
- Published by Springer Nature in Nature
- Vol. 646 (8084) , 281-283
The cutting-edge medical approaches that could transform ageing
- 6 October 2025
- Published by Springer Nature in Nature
- Vol. 646 (8084) , 281-283
The cutting-edge medical approaches that could transform ageing
- Open Access
- 17 July 2025
- Published by Elsevier in Cell Reports
- Vol. 44 (8) , 116016
Single-nucleus neuronal transcriptional profiling of male C. elegans uncovers regulators of sex-specific and sex-shared behaviors
- 17 July 2025
- Published by Elsevier in Cell Reports
- Vol. 44 (8) , 116016
Open AccessSingle-nucleus neuronal transcriptional profiling of male C. elegans uncovers regulators of sex-specific and sex-shared behaviors
- Open Access
- 11 July 2025
- Published by Cold Spring Harbor Laboratory in Genes & Development
- Vol. 39 (15-16) , 933-935
C. elegans cognitive decline with age: more than just wiggling forward and backward
Caenorhabditis elegans has been at the forefront of research on mechanisms of age-related decline for the past 30 years. Despite its popularity in longevity research, C. elegans is underappreciated for its potential to study complex behaviors and the progressive decline in these functions with age. Using assays of learning and memory, we have identified genetic pathways that regulate these behaviors and identified new mechanisms to boost these functions with age in both worms and mice. Because C. elegans is so highly conserved, some of these recently described mechanisms may be good targets to prevent human cognitive decline with age.
- 11 July 2025
- Published by Cold Spring Harbor Laboratory in Genes & Development
- Vol. 39 (15-16) , 933-935
Open AccessC. elegans cognitive decline with age: more than just wiggling forward and backward
Caenorhabditis elegans has been at the forefront of research on mechanisms of age-related decline for the past 30 years. Despite its popularity in longevity research, C. elegans is underappreciated for its potential to study complex behaviors and the progressive decline in these functions with age. Using assays of learning and memory, we have identified genetic pathways that regulate these behaviors and identified new mechanisms to boost these functions with age in both worms and mice. Because C. elegans is so highly conserved, some of these recently described mechanisms may be good targets to prevent human cognitive decline with age.